Pharmacological management of bipolar disorder: Japanese expert consensus-Reference-Cited by-同舟云学术

Pharmacological management of bipolar disorder: Japanese expert consensus

Published:2020-07-02 Issue:8 Volume:22 Page:822-830
ISSN:1398-5647
Container-title:Bipolar Disorders
language:en
Short-container-title:Bipolar Disord.

Author:

Sakurai Hitoshi¹²^ORCID,Kato Masaki³^ORCID,Yasui-Furukori Norio⁴,Suzuki Takefumi⁵,Baba Hajime⁶,Watanabe Koichiro⁷,Inada Ken⁸,Kishida Ikuko⁹¹⁰,Sugawara Kikuchi Yuka¹¹,Kikuchi Toshiaki²,Katsuki Asuka¹²,Uchida Hiroyuki²^ORCID,

Affiliation:

1. Department of Psychiatry Massachusetts General Hospital Boston MA USA

2. Department of Neuropsychiatry Keio University School of Medicine Tokyo Japan

3. Department of Neuropsychiatry Kansai Medical University Osaka Japan

4. Department of Psychiatry Dokkyo Medical University School of Medicine Tochigi Japan

5. Department of Neuropsychiatry University of Yamanashi Faculty of Medicine Yamanashi Japan

6. Department of Psychiatry & Behavioral Science Juntendo University Graduate School of Medicine Tokyo Japan

7. Department of Neuropsychiatry Kyorin University School of Medicine Tokyo Japan

8. Department of Psychiatry Tokyo Women's Medical University School of Medicine Tokyo Japan

9. Fujisawa Hospital Kanagawa Japan

10. Department of Psychiatry Yokohama City University School of Medicine Kanagawa Japan

11. Department of Psychiatry Akita University School of Medicine Akita Japan

12. Department of Psychiatry University of Occupational and Environmental Health Fukuoka Japan

Funder

GlaxoSmithKline

Publisher

Wiley

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bdi.12959

Reference25 articles.

1. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 2: review, grading of the evidence, and a precise algorithm;Fountoulakis KN;Int J Neuropsychopharmacol,2017

2. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

3. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder

4. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder

5. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical decision support for bipolar depression using large language models;Neuropsychopharmacology;2024-03-13

2. Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder;Journal of Clinical Psychopharmacology;2024-03

3. Diagnosis and Treatment of Bipolar Disorder;JAMA;2023-10-10

4. Taiwan consensus on biological treatment of bipolar disorder during the acute, maintenance, and mixed phases: The 2022 update;Asian Journal of Psychiatry;2023-04

5. Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics;Current Neuropharmacology;2023-04